However, this strategy often requires the use of HLA-A*02:01-restricted peptides, such as E75 (HER2/neu 369-377) and GP2 (HER2/neu 654-662), to activate T cells, in order to enhance their ability to effectively kill tumor cells. This evidence concerns the gene HLA-A and neoplasm.